Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Video

» Interview

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs Ticagrelor With Aspirin in STEMI

October 14, 2020

Video

» Topical Discussion

Stopping Amputation Post-revascularization: Novel Data in Mitigation of Thrombosis Risk

June 27, 2022

Video

» Interview

Sex-Specific Outcomes in TWILIGHT: Ticagrelor With or Without Aspirin After PCI

May 24, 2021

Video

Reducing Aspirin Use in ACS and PCI (With and Without AFib): How Good Is the Evidence?

October 16, 2019

Video

Reducing Aspirin Use in ACS and PCI

February 24, 2020

Video

» Topical Discussion

Quick Takes: James Freeman on Forgoing Aspirin in Post-LAAO Regimens

September 13, 2024

Video

» Interview

HOST-EXAM: Aspirin vs Clopidogrel During Chronic Maintenance Monotherapy After PCI

May 20, 2021

Video

Evidence for Chronic Aspirin use in CV patients: COMPASS and More

October 16, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Usman Baber About the TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

September 28, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Roxana Mehran About TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

September 27, 2019

Video

» Interview

Beyond the Data: STOPDAPT-3–Is Aspirin-Free an Option?

August 31, 2023

Video

Aspirin Variability Interactions and Formulations

February 24, 2020

Video

Aspirin Use for Primary Secondary Prevention: Critical Appraisal of What We Know and What We Don't

October 17, 2019

Advertisement

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs Ticagrelor With Aspirin in STEMI

Stopping Amputation Post-revascularization: Novel Data in Mitigation of Thrombosis Risk

Sex-Specific Outcomes in TWILIGHT: Ticagrelor With or Without Aspirin After PCI

Reducing Aspirin Use in ACS and PCI (With and Without AFib): How Good Is the Evidence?

Reducing Aspirin Use in ACS and PCI

Quick Takes: James Freeman on Forgoing Aspirin in Post-LAAO Regimens

HOST-EXAM: Aspirin vs Clopidogrel During Chronic Maintenance Monotherapy After PCI

Evidence for Chronic Aspirin use in CV patients: COMPASS and More

Dr. C. Michael Gibson Talks With Dr. Usman Baber About the TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Dr. C. Michael Gibson Talks With Dr. Roxana Mehran About TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Beyond the Data: STOPDAPT-3–Is Aspirin-Free an Option?

Aspirin Variability Interactions and Formulations

Aspirin Use for Primary Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content